Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, Divi's Laboratories has submitted the details as required under Para B of Part A of Schedule III of the Regulations read Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.
The above information is a part of company’s filings submitted to BSE.